Phase I results will be presented at the International Conference on Mucosal Vaccines, Adjuvants & Delivery, in Copenhagen

In September results of the clinical Phase I study of our novel vaccine against diarrhea caused by ETEC will be presented at the International Conference on Mucosal Vaccines, Adjuvants & Delivery, in Copenhagen. Mucosal Vaccines, Adjuvants and Delivery is a three day conference (25-27 September) and its key focus will be on the requirements and […]